Goldman Sachs invests $20 M in China biotech firm

ChinaEnterprise Innovation — Goldman Sachs recently completed a $20 million investment in Ascletis, a China-based biotechnology company focused on innovative drug development. Within the past two months, Ascletis has completed two rounds of financing, with the first round of $35 million investment led by C-Bridge Capital, Tasly Pharmaceutical, and Pavilion Capital.

http://enterpriseinnovation.net/article/goldman-sachs-invests-20-m-china-biotech-firm-1429462593

Goldman Sachs eyes China’s mobile content market with investment in Wandoujia

Chinese mobile content search engine and Android app store Wandoujia today announced it closed its series B round of financing with a follow-on investment from US investment bank Goldman Sachs. The undisclosed amount of funding comes just after Wandoujia’s $120 million funding led by Japanese mobile telco SoftBank. Wandoujia says this is Goldman Sachs’ first investment in a Chinese mobile internet company. Other Goldman Sachs investments in Chinese online firms include ebook platform Shanda Cloudary and Shanghai-based pet product store Boqii.

http://www.techinasia.com/goldman-sachs-eyes-chinas-mobile-content-market-investment-wandoujia/